bpc157 & tb500

Activates vascular endothelial growth factor receptor-2 (VEGFR2) pathway and nitric oxide synthesis via Akt-endothelial nitric oxide synthase (eNOS) axis, promoting robust angiogenesis critical for healing poorly vascularized tissues like tendons and ligaments. Upregulates VEGF gene and protein expression in injured tissues, inducing CD34-positive endothelial progenitor cell recruitment and FVIII-positive blood vessel formation. Modulates Src and caveolin-1 phosphorylation for sustained nitric oxide production maintaining vessel dilation and continuous blood flow to healing sites. Also activates VEGF-independent pathways ensuring multi-modal vascular support.

Activates focal adhesion kinase (FAK)-paxillin signaling pathway critical for cellular adhesion, migration, proliferation, and survival. Significantly accelerates tendon explant outgrowth and markedly increases fibroblast migration in dose-dependent manner without directly affecting cell proliferation. Enhances cell survival under oxidative stress (H₂O₂) by improving stress resistance. Increases growth hormone receptor (GHR) expression in fibroblasts augmenting anabolic healing response, improving tendon structure and biomechanical function even under corticosteroid impairment or limited vascular supply. Promotes extracellular matrix assembly and collagen synthesis essential for structural tissue integrity.

Upregulates phosphorylation of extracellular signal-regulated kinases (ERK) 1 and 2 with downstream activation of c-Fos, c-Jun, and Early Growth Response gene 1 (Egr-1)—key molecules in cell growth, migration, and angiogenesis. Activates AKT phosphorylation and increases KRAS gene expression for pro-survival and pro-proliferation effects. Reduces inflammatory mediators: downregulates COX-2 (cyclooxygenase-2), MPO (myeloperoxidase), IL-6 (interleukin-6), and TNF-α (tumor necrosis factor-alpha) creating anti-inflammatory environment conducive to healing. Modulates NF-κB pathway reducing harmful excessive inflammatory responses while preserving necessary healing inflammation.

Forms 1:1 complex with globular actin (G-actin) monomers preventing premature actin polymerization, functioning as principal actin-sequestering molecule with intracellular concentrations reaching 0.5 mM. Acts as buffer for monomeric actin driving dynamic cytoskeletal reorganization essential for cell migration, morphology changes, and wound contraction. Upon cellular activation, releases G-actin monomers enabling rapid F-actin (filamentous actin) polymerization for cell motility and structural remodeling. Critical actin-binding motif (LKKTET sequence at residues 17-22) interacts along entire peptide length with actin complex. Low molecular weight (4.9 kDa) and lack of extracellular matrix binding enable systemic distribution and tissue-wide effects without requiring local injection.

Reactivates embryonic cardiac gene program by thickening epicardial monolayer and mobilizing epicardium-derived progenitor cells (EPDCs) that differentiate into cardiomyocytes, cardiac fibroblasts, vascular smooth muscle cells, and pericytes. Promotes myocardial cell survival under hypoxia through Akt activation via integrin-linked kinase (ILK) and focal adhesion complex binding, reducing cardiomyocyte apoptosis. Stimulates neoangiogenesis in cardiac tissue improving perfusion to ischemic regions. First known molecule capable of simultaneous myocardial and vascular regeneration after systemic administration, demonstrated to reduce infarct volume and preserve cardiac function in myocardial infarction models through coordinated tissue repair mechanisms.

Promotes migration, proliferation, and differentiation of stem/progenitor cells forming new blood vessels and regenerating tissue across multiple organ systems. Decreases myofibroblast numbers in wounds reducing scar formation and fibrosis for improved functional tissue restoration. Protects cells from apoptosis, reduces inflammation and microbial growth creating optimal healing environment. Keratinocyte migration stimulated 2-3-fold at concentrations as low as 10 pg, accelerating re-epithelialization by 42-61% in wound models with increased collagen deposition. Upregulated in pathological conditions (focal ischemia, neurodegenerative diseases, seizures) suggesting neuroprotective role in CNS including synaptogenesis, axon growth, and neuroplasticity. Modulates inflammatory cytokines shifting from pro-inflammatory to pro-healing state.